secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senseonics Holdings, Inc. (SENS)
CIK:        0001616543
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001558370-25-002038
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senseonics Q4 revenue $8.3M, net loss $15.5M; guides FY25 revenue $34-38M
-------------------------------------------------------------------------

- Q4 revenue $8.3M (up from $8.0M YoY); net loss $15.5M ($0.02 loss per share).
- Full-year 2024 revenue $22.5M (flat YoY); net loss $78.6M ($0.12 loss per share).
- Patient base grew 56% in 2024 to ~6,000 global patients; Eversense 365 FDA approved and launched.
- FY2025 guidance: revenue $34-38M, gross margins 25-30%, cash usage $50-60M.
- Post-quarter: raised ~$27M via ATM, repaid $20.4M convertible notes; debt reduced to $35M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1616543/000155837025002038/0001558370-25-002038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1616543/000155837025002038/sens-20250303x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-002038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer